Viral infections such as the hepatitis B virus (HBV) are noted disparities faced by Asian American communities. Additionally, Asian Americans face a disproportionate burden of liver cancer. CSAAH has implemented several research studies to understand the relationships between HBV and liver cancer in Asian communities.

Asian American Hepatitis B Program (AAHBP)
Hepatitis B is estimated to affect 400 children and adults worldwide; yet it remains a relatively unknown, silent killer that can lead to cirrhosis and liver cancer. American-born children have been vaccinated against Hepatitis B since 1982, but lack of preventive care has left many adults and foreign-born children without similar protection.

The Asian American Hepatitis B Program (AAHBP) is a coalition of New York City institutions and residents dedicated to reducing the disproportionate burden of the hepatitis B infection on the Asian American community through outreach, education, screening, vaccinations, and follow-up care.

Established in 2004 with funding from the New York City Council, the AAHBP also supports collaborative research in the epidemiology of hepatitis B infection in the Asian American community in NYC, outcomes evaluation, and policy development. In 2006 the AAHBP through the B Free, C Free, HIV Free Campaign expanded its outreach and services to the Latin American, Caribbean, African, East European immigrant communities in New York City who are also at higher risk for hepatitis B, as well as for co-infection with Hepatitis C and HIV.

Find out more about the Institute’s B Free, C Free, HIV Free Campaign.